Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 4 Open-market buy 10% owner bought 4,000,000 shares at $0.50 ($2,000,000)
  2. 8-K Event Material agreement · Other events
  3. 424B5 Offering Prospectus
  4. EFFECT Other Notice of Effectiveness
  5. CERT Other Certification
  6. 8-A12B Other Registration of Securities
  7. S-1/A Offering Registration Statement
  8. S-1/A Offering Registration Statement
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-1 Offering Registration Statement
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 8-K Event Regulation FD disclosure
  15. 10-Q Report Quarterly Report
  16. DRS Other Draft Registration Statement
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 10-Q Report Quarterly Report
  20. 4 Option exercise Sr. VP of Finance acquired 30 shares (option exercise)

Page 3 of 77 · 1,525 filings